^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
Altera

Company:
Natera
Type:
Laboratory Developed Test
Related tests:

Details

Evidence
Altera tumor genomic profiling offers a whole exome and transcriptome-based approach for Comprehensive Genomic Profiling (CGP) with boosted >500X coverage for 440 medically important genes. As a result, Altera provides full details on known cancer driver genes as well as less common biomarkers.
Gene:
ABL1 (ABL proto-oncogene 1), AKT1 (V-akt murine thymoma viral oncogene homolog 1), ARID1A (AT-rich interaction domain 1A), ARID1B (AT-Rich Interaction Domain 1B), AURKA (Aurora kinase A), AURKB (Aurora Kinase B)
See More ...
Method:
Next generation sequencing (NGS)